摘要:
                                Ganglioside GM(3) and KDN-ganglioside GM(3), containing hexanoyl, decanoyl, and hexadecanoyl groups at the ceramide moiety have been synthesized. Selective reduction of the azido group in O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D -gIycero-alpha-D-galacro-2-nonulopyranosylonate)-(2-->3)-O-(2,4-di-O-acetyl-6-O-benzoyl-beta-D-galactopyranosyl) (1-->4)-O-(3-O-acetyl-2,6-di-O-benzoyl-beta-D-glucopyranosyl)-(1-->1)-(2S,3R,4E)-2-azid-3-O-benzoyl-4-octadecene-1,3-diol (1) and O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-gIycero-alpha-D-galacto-2- nonulopyranosylonate)-(2-->3)-O-(2,4-di-O-acetyl-6-O-benzoyl-beta-D-galactopyranosyl)-(1-->4)-O-(3-O-acetyl-2,6-di-O-benzoyl-beta-D-glucopyranosyl)-(1-->1)-(2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene- 1,3-diol (2), coupling with hexanoic, decanoic, and hexadecanoic acids, O-deacylation, and de-esterification gave the title gangliosides GM(3) (11 similar to 13) and KDN-GM(3) (14 similar to 16) in good yields. On the other hand, O-deacylation of 1 and subsequent de-esterification gave 2-azido-sphingosine containing-GM(3) analogue 17, which was converted into lyso-GM(3), in which no fatty acyl group was substituted at the sphingosine residue, by selective reduction of the azido group.